CRJZ has continuously received a Wind ESG A rating, with a comprehensive score of 7.82同壁财经·May 30, 2026 at 03:32 PM600750-0.04%
China Resources Pharma's subsidiary China Resources Jiangzhong earned 907 million RMB last year, an increase of 15%AASTOCKS·Mar 19, 2026 at 02:22 PM03320-1.79%600750-0.04%
China Resources Pharma's subsidiary China Resources Jiangzhong earned 906 million RMB last year, an increase of 15%AASTOCKS·Jan 25, 2026 at 09:47 AM600750-0.04%03320-1.79%
China Resources Pharmaceutical: JZYY's net profit for the first three quarters is 743 million yuan, an increase of 6.02% year-on-yearZhitong·Oct 24, 2025 at 09:44 AM600750-0.04%
JZYY: The net profit attributable to the parent company in the third quarter was 161 million yuan, an increase of 4.70% year-on-yearZhitong·Oct 24, 2025 at 09:26 AM600750-0.04%
Zhongtai Securities: The gross profit margin of the Chinese medicine sector is expected to recover in H2 2025, optimistic about leading brands in OTC and innovative pipelinesZhitong·Sep 2, 2025 at 11:41 PM600750-0.04%000999+1.64%
The heavy holdings of brokerages in the second quarter have been released, favoring industries such as basic chemicals, machinery and equipment, automobiles, and pharmaceuticals and biotechnologyWallstreetcn·Aug 31, 2025 at 11:19 PM600750-0.04%002145-1.86%
China Resources Pharmaceutical: JZYY's net profit attributable to the parent company in the first half of the year was approximately 522 million yuan, a year-on-year increase of 5.8%Zhitong·Aug 21, 2025 at 10:25 AM600750-0.04%
JZYY plans to invest 40 million yuan in the China Resources Pharmaceutical Industry Investment Fund Phase IIZhitong·Jul 17, 2025 at 08:39 AM600750-0.04%
CICC: Assigns JZYY an initial rating of outperforming the marketZhitong·Jun 18, 2025 at 12:16 AM600750-0.04%
Overview of the lifting of restrictions on the sale of A-shares | May 30Zhitong·May 30, 2025 at 03:08 AM002025+2.90%600057-1.66%
China Resources Pharmaceutical: JZYY achieved a net profit of 307 million yuan in the first quarter, a year-on-year increase of 6.15%Zhitong·Apr 28, 2025 at 12:08 AM600750-0.04%
JZYY released its first-quarter performance, with a net profit attributable to the parent company of 285 million yuan, a year-on-year increase of 5.91%Zhitong·Apr 25, 2025 at 03:46 PM600750-0.04%
JZYY released its 2024 annual performance, with a net profit attributable to the parent company of 788 million yuan, a year-on-year increase of 9.67%Zhitong·Mar 19, 2025 at 12:36 PM600750-0.04%
China Resources Pharmaceutical: JZYY's annual net profit attributable to shareholders is 785 million yuan, a year-on-year increase of 9.22%Zhitong·Jan 24, 2025 at 12:12 PM600750-0.04%
